Trial reportFrontiers in pediatrics2026
The use of motion tracking technology to support an exercise intervention for children and young people with cancer: perspectives of users and healthcare professionals in the FORTEe trial.
Trial report in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05289739 (Get Strong to Fight Childhood Cancer), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Get Strong to Fight Childhood Cancer: An Exercise Intervention for Children and Adolescents Undergoing Anti-Cancer Treatment
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Technological advances provide new approaches to improving oncology care. Research indicates that supportive technological tools can benefit children with cancer, and integrating technology into exercise-based interventions may enhance physical activity and reduce fatigue. The FORTEe clinical trial incorporated a motion tracking device (Pixformance) within a broader, individualised exercise intervention for children and young adults (CAYA) with cancer. The device used an inbuilt camera, avatar-led demonstrations, and real-time feedback on exercise form. This FORTEe sub-study explored the perspectives of CAYA with cancer and exercise and healthcare professionals (EHCP) on using this motion tracking technology. Methods: CAYA aged 4-21 years and EHCP from five participating centres were eligible. Experiences and perceptions were explored through semi-structured interviews with CAYA and an anonymous online survey for EHCP. The CAYA interviews and open-ended text from the EHCP survey were analysed using an inductive content analysis approach. Results: Ninety CAYA (mean age 11.1 ± 3.7 years; 44.4% female) participated in interviews and 33 EHCP completed the survey. CAYA found the device a novel and useful addition to conventional training, appreciating its variety of exercises and real-time guidance. Some technical issues affected motion detection consistency. EHCP recognised benefits for supervised exercise but highlighted challenges with transport and offline use. CAYA also suggested adding gamification features such as rewards, avatar customisation, and competition. Conclusion: The motion tracking device was well received by both CAYA and EHCP. Findings suggest this technology could complement conventional exercise interventions and provide insights for optimising efficiency, motivation, and user experience in clinical settings. Clinical Trial Registration: ClinicalTrials.gov (NCT05289739).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.